Renascience Inc. (TYO:4889)

Renascience Statistics

Total Valuation

Renascience has a market cap or net worth of JPY 19.46 billion. The enterprise value is 17.90 billion.

Market Cap	19.46B
Enterprise Value	17.90B

Important Dates

The next estimated earnings date is Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Renascience has 13.25 million shares outstanding.

Current Share Class	13.25M
Shares Outstanding	13.25M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	23.55%
Owned by Institutions (%)	2.04%
Float	10.01M

Valuation Ratios

The trailing PE ratio is 572.48.

PE Ratio	572.48
Forward PE	n/a
PS Ratio	223.73
PB Ratio	12.41
P/TBV Ratio	12.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	526.45
EV / Sales	205.74
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.76

Current Ratio	14.76
Quick Ratio	13.76
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 2.19% and return on invested capital (ROIC) is -9.95%.

Return on Equity (ROE)	2.19%
Return on Assets (ROA)	-9.48%
Return on Invested Capital (ROIC)	-9.95%
Return on Capital Employed (ROCE)	-17.59%
Weighted Average Cost of Capital (WACC)	14.87%
Revenue Per Employee	29.00M
Profits Per Employee	11.33M
Employee Count	3
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

In the past 12 months, Renascience has paid 30.00 million in taxes.

Income Tax	30.00M
Effective Tax Rate	46.88%

Stock Price Statistics

The stock price has increased by +22.42% in the last 52 weeks. The beta is 1.93, so Renascience's price volatility has been higher than the market average.

Beta (5Y)	1.93
52-Week Price Change	+22.42%
50-Day Moving Average	1,614.58
200-Day Moving Average	1,894.59
Relative Strength Index (RSI)	43.23
Average Volume (20 Days)	192,045

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Renascience had revenue of JPY 87.00 million and earned 34.00 million in profits. Earnings per share was 2.67.

Revenue	87.00M
Gross Profit	82.00M
Operating Income	-276.00M
Pretax Income	64.00M
Net Income	34.00M
EBITDA	n/a
EBIT	-276.00M
Earnings Per Share (EPS)	2.67

Balance Sheet

The company has 1.57 billion in cash and n/a in debt, with a net cash position of 1.57 billion or 118.11 per share.

Cash & Cash Equivalents	1.57B
Total Debt	n/a
Net Cash	1.57B
Net Cash Per Share	118.11
Equity (Book Value)	1.57B
Book Value Per Share	123.35
Working Capital	1.57B

Cash Flow

Operating Cash Flow	-277.00M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 94.25%, with operating and profit margins of -317.24% and 39.08%.

Gross Margin	94.25%
Operating Margin	-317.24%
Pretax Margin	73.56%
Profit Margin	39.08%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Renascience does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	0.17%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Renascience has an Altman Z-Score of 87.08 and a Piotroski F-Score of 1.

Altman Z-Score	87.08
Piotroski F-Score	1